ZAQS.ORG

Marty Makary resigns as FDA commissioner following industry and White House backlash

1 day ago

Novo Nordisk: High-dose Wegovy caused nearly 28% weight loss in some patients

1 day ago

Jim Cramer says today's market is punishing stocks harder than 1999

2 days ago

Hantavirus cases spark brief surge in pharma and biotech stocks — here's why trading is so volatile

2 days ago

Cruise ship hantavirus outbreak: An expedition boom and new world of travel risk

2 days ago

Fitness wearable Whoop to offer on-demand clinician access to U.S. users

5 days ago

Healthy Returns: Novo Nordisk faces Ozempic generics in Canada

5 days ago

Planet Fitness stock plunges 30% after company slashes guidance

6 days ago

Family office deal-making rebounds in April with healthcare bets

6 days ago

Rare disease families find roadmap to drug development at bootcamps

6 days ago

Novo Nordisk CEO says the drugmaker is more active than ever for dealmaking

6 days ago

Wearable patches: How Barrière is trying to disrupt the supplement industry

7 days ago

CVS blows past estimates, hikes outlook as insurance business outperforms

7 days ago

FDA withdrew studies finding Covid and shingles vaccines were safe

7 days ago

FDA commissioner defends agency's drug approval decisions after wave of backlash

8 days ago

Major health insurers show early strength – but a key test looms in Q2

8 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

8 days ago

Novo's head start on GLP-1 pills forces investors to rethink Lilly's dominance

8 days ago

Weight loss and hair loss: The growing hair treatment market from GLP-1s

11 days ago

Cardinal Health's sell-off on earnings was an overreaction. We'd be buyers

12 days ago

Trump picks Nicole Saphier for surgeon general after pulling Casey Means

12 days ago

Eli Lilly shares surge on a beat-and-raise, proving the stock's swoon was a mistake

13 days ago

FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list

13 days ago

More than 20,000 people are taking Eli Lilly's weight loss pill Foundayo, CEO says

13 days ago

Merck beats quarterly estimates on strength of Keytruda, narrows outlook

13 days ago

Eli Lilly blows past quarterly estimates, hikes outlook

13 days ago

Novartis CEO warns reality of Trump's drug pricing policy will set in over 'the next 18 months'

16 days ago

Pharma bets on a little-known cholesterol for its next blockbuster heart drugs

16 days ago

Spotify teams up with Peloton to launch global fitness content hub

16 days ago

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

16 days ago

Regeneron weighs overseas price for gene therapy for rare type of hearing loss

16 days ago

FDA fast-tracks psychedelic drug research following Trump executive order

19 days ago